Product image of Liprolog Mix25 (Insulin Lispro) supplied by GNH India

Liprolog Mix25

Active Ingredient:
Insulin Lispro
Origin:
EU

Liprolog Mix25 (Insulin Lispro)

Insulin lispro, the active ingredient in Liprolog Mix25, is a rapid‑acting insulin analog presented as a subcutaneous injectable formulation for subcutaneous use. It is used to lower blood glucose in patients with type 1 and type 2 diabetes mellitus. It acts quickly after injection, mimicking the body’s natural insulin response to meals.

GNH India supplies Liprolog Mix25 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Eli Lilly Nederland B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Insulin lispro is a rapid‑acting insulin analog used to manage hyperglycaemia in diabetes.

  • Type 1 diabetes mellitus: improves post‑prandial glucose control.
  • Type 2 diabetes mellitus: assists in achieving glycaemic targets when combined with other therapies.
  • Meal‑time insulin supplementation: provides rapid glucose lowering after meals.

How It Works

  • Insulin lispro binds to the insulin receptor on cell membranes, activating the receptor’s intrinsic tyrosine kinase activity. This triggers downstream signaling pathways that promote translocation of GLUT‑4 transporters to the cell surface, enhancing glucose uptake in muscle and adipose tissue, while simultaneously suppressing hepatic glucose production, resulting in lowered blood glucose levels.

Side Effects

Common Side Effects

  • Hypoglycaemia: symptoms of low blood sugar such as shakiness, sweating, and confusion.
  • Injection site reactions: redness, swelling, or itching at the injection site.
  • Weight gain: modest increase in body weight with chronic use.
  • Lipodystrophy: localized changes in subcutaneous fat.
  • Localized allergic reaction: itching or rash at injection site.

Serious or Rare Side Effects

  • Severe hypoglycaemia: profound low blood glucose requiring assistance.
  • Anaphylaxis: systemic allergic reaction with difficulty breathing or swelling.
  • Hypokalemia: low potassium levels, especially with high insulin doses.
  • Insulin antibody formation: may alter insulin effectiveness.
  • Acute pancreatitis: rare inflammation of the pancreas.

Precautions & Warnings

Before initiating therapy, consider individual patient factors and monitor regularly.

  • Dose individualisation: titrate according to blood glucose monitoring and clinical response.
  • Hypoglycaemia risk: educate patients on recognising and treating low blood sugar.
  • Renal impairment: adjust dose as reduced clearance may increase effect.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Insulin lispro may interact with several concomitant medications.

Major Interactions (Avoid)

  • Sulfonylureas: additive hypoglycaemia risk.
  • Beta‑blockers: may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: can enhance insulin sensitivity, requiring dose adjustment.
  • Thiazide diuretics: may increase blood glucose levels.
  • Corticosteroids: may necessitate higher insulin doses due to hyperglycaemic effect.

Frequently Asked Questions

Liprolog Mix25 contains insulin lispro, a rapid‑acting insulin analog prescribed to lower elevated blood glucose in adults and children with type 1 or type 2 diabetes mellitus. It is typically administered before meals to control post‑prandial glucose spikes.

Insulin lispro binds to insulin receptors on muscle, fat, and liver cells, activating intracellular pathways that increase glucose uptake and inhibit hepatic glucose production. This rapid action mimics the body’s natural insulin response to food, helping to normalise blood sugar levels.

The dose of Liprolog Mix25 is individualized by the prescribing healthcare professional based on the patient’s blood glucose readings, meal patterns, and overall treatment plan. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Insulin lispro is classified as a pregnancy category that may be used when the expected benefit outweighs potential risk. It is excreted in breast milk in small amounts, and continuation during breastfeeding should be decided by the treating physician.

To request Liprolog Mix25, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling) and import documentation.

Liprolog Mix25 (insulin lispro) has a rapid onset of action similar to other rapid‑acting analogues such as insulin aspart and insulin glulisine. It differs in its molecular structure, which may influence absorption speed and individual patient tolerance, but all are designed for mealtime glucose control.

Store Liprolog Mix25 refrigerated at 2‑8 °C, protected from light. Do not freeze or shake the vial. Once in use, it may be kept at controlled room temperature (up to 30 °C) for a maximum of 28 days, as specified on the label.

Liprolog Mix25 is administered by subcutaneous injection, usually into the abdomen, thigh, or upper arm. The injection should be given shortly before meals, following the dosing schedule prescribed by the healthcare provider.

The most serious risks include severe hypoglycaemia, which can cause loss of consciousness or seizures, and rare allergic reactions such as anaphylaxis. Patients should be educated on recognising symptoms and have a plan for immediate treatment.

Liprolog Mix25 should be avoided in individuals with a known hypersensitivity to insulin lispro or any excipients in the formulation. It is also contraindicated in patients with severe hypoglycaemia unresponsive to treatment until the underlying cause is resolved.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Insulin Lispro

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT